on EUROPLASMA (EPA:ALEUP)
EUROPLASMA: 2024 annual results and outlook for 2025
Europlasma announces a significant increase in its revenue in 2024, reaching €42.5 million, an increase of 176%. This growth is mainly attributable to the high activity of Forges de Tarbes and the integration of Valdunes Industries. Revenue per employee also increased by 30%. Although EBITDA recorded a slight decrease, improvements were noted on a like-for-like basis.
Net profit reported a loss of €15.9 million, with debt improving to 32.2% of revenue from 83% the previous year. The outlook for 2025 is optimistic, with the group aiming for strong sales momentum, particularly in the defense sector.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EUROPLASMA news